Page last updated: 2024-10-31

midazolam and Benign Intracranial Hypertension

midazolam has been researched along with Benign Intracranial Hypertension in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McArthur, CJ1
Gin, T1
McLaren, IM1
Critchley, JA1
Oh, TE1
Weinstabl, C1
Spiss, CK1

Trials

1 trial available for midazolam and Benign Intracranial Hypertension

ArticleYear
Gastric emptying following brain injury: effects of choice of sedation and intracranial pressure.
    Intensive care medicine, 1995, Volume: 21, Issue:7

    Topics: Acetaminophen; Adult; Brain Injuries; Conscious Sedation; Drug Therapy, Combination; Female; Gastric

1995

Other Studies

1 other study available for midazolam and Benign Intracranial Hypertension

ArticleYear
Fentanyl and sufentanil increase intracranial pressure in head trauma patients.
    Anesthesiology, 1993, Volume: 78, Issue:3

    Topics: Craniocerebral Trauma; Fentanyl; Humans; Intracranial Pressure; Midazolam; Morphine; Pseudotumor Cer

1993